PEPGEN INC (PEPG) Fundamental Analysis & Valuation

NASDAQ:PEPGUS7133171055

Current stock price

4.52 USD
-0.37 (-7.57%)
At close:
4.52 USD
0 (0%)
After Hours:

This PEPG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PEPG Profitability Analysis

1.1 Basic Checks

  • PEPG had negative earnings in the past year.
  • PEPG had a negative operating cash flow in the past year.
  • PEPG had negative earnings in each of the past 5 years.
  • PEPG had a negative operating cash flow in each of the past 5 years.
PEPG Yearly Net Income VS EBIT VS OCF VS FCFPEPG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -51.55%, PEPG is in line with its industry, outperforming 47.59% of the companies in the same industry.
  • The Return On Equity of PEPG (-60.81%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -51.55%
ROE -60.81%
ROIC N/A
ROA(3y)-55.38%
ROA(5y)-43.39%
ROE(3y)-69.73%
ROE(5y)-53.63%
ROIC(3y)N/A
ROIC(5y)N/A
PEPG Yearly ROA, ROE, ROICPEPG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60

1.3 Margins

  • PEPG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PEPG Yearly Profit, Operating, Gross MarginsPEPG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

8

2. PEPG Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for PEPG has been increased compared to 1 year ago.
  • The number of shares outstanding for PEPG has been increased compared to 5 years ago.
  • PEPG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PEPG Yearly Shares OutstandingPEPG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
PEPG Yearly Total Debt VS Total AssetsPEPG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • PEPG has an Altman-Z score of 3.93. This indicates that PEPG is financially healthy and has little risk of bankruptcy at the moment.
  • PEPG has a Altman-Z score of 3.93. This is in the better half of the industry: PEPG outperforms 71.29% of its industry peers.
  • There is no outstanding debt for PEPG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.93
ROIC/WACCN/A
WACCN/A
PEPG Yearly LT Debt VS Equity VS FCFPEPG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 11.94 indicates that PEPG has no problem at all paying its short term obligations.
  • PEPG has a Current ratio of 11.94. This is amongst the best in the industry. PEPG outperforms 85.36% of its industry peers.
  • A Quick Ratio of 11.94 indicates that PEPG has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 11.94, PEPG belongs to the top of the industry, outperforming 85.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.94
Quick Ratio 11.94
PEPG Yearly Current Assets VS Current LiabilitesPEPG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

1

3. PEPG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 15.20% over the past year.
EPS 1Y (TTM)15.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • PEPG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.05% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y43.77%
EPS Next 2Y23.94%
EPS Next 3Y20.37%
EPS Next 5Y19.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PEPG Yearly Revenue VS EstimatesPEPG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
PEPG Yearly EPS VS EstimatesPEPG Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15 -20

1

4. PEPG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PEPG. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PEPG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PEPG Price Earnings VS Forward Price EarningsPEPG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PEPG Per share dataPEPG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PEPG's earnings are expected to grow with 20.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.94%
EPS Next 3Y20.37%

0

5. PEPG Dividend Analysis

5.1 Amount

  • PEPG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PEPG Fundamentals: All Metrics, Ratios and Statistics

PEPGEN INC

NASDAQ:PEPG (3/27/2026, 8:00:00 PM)

After market: 4.52 0 (0%)

4.52

-0.37 (-7.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners91.56%
Inst Owner Change1.31%
Ins Owners0.18%
Ins Owner Change10.87%
Market Cap312.42M
Revenue(TTM)N/A
Net Income(TTM)-89.66M
Analysts86.15
Price Target11.07 (144.91%)
Short Float %3.91%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.52%
Min EPS beat(2)9.77%
Max EPS beat(2)29.28%
EPS beat(4)3
Avg EPS beat(4)7.71%
Min EPS beat(4)-25.27%
Max EPS beat(4)29.28%
EPS beat(8)6
Avg EPS beat(8)8.99%
EPS beat(12)9
Avg EPS beat(12)8.31%
EPS beat(16)11
Avg EPS beat(16)-10.37%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.67%
PT rev (3m)1.67%
EPS NQ rev (1m)11.94%
EPS NQ rev (3m)11.94%
EPS NY rev (1m)-0.4%
EPS NY rev (3m)-0.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.12
P/tB 2.12
EV/EBITDA N/A
EPS(TTM)-2.41
EYN/A
EPS(NY)-1.36
Fwd EYN/A
FCF(TTM)-1.18
FCFYN/A
OCF(TTM)-1.18
OCFYN/A
SpS0
BVpS2.13
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -51.55%
ROE -60.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-55.38%
ROA(5y)-43.39%
ROE(3y)-69.73%
ROE(5y)-53.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.9%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.94
Quick Ratio 11.94
Altman-Z 3.93
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)90.48%
Cap/Depr(5y)263.31%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.41%
EPS Next Y43.77%
EPS Next 2Y23.94%
EPS Next 3Y20.37%
EPS Next 5Y19.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-12.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.89%
OCF growth 3YN/A
OCF growth 5YN/A

PEPGEN INC / PEPG Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PEPGEN INC (PEPG) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PEPG.


What is the valuation status of PEPGEN INC (PEPG) stock?

ChartMill assigns a valuation rating of 1 / 10 to PEPGEN INC (PEPG). This can be considered as Overvalued.


What is the profitability of PEPG stock?

PEPGEN INC (PEPG) has a profitability rating of 1 / 10.


What is the earnings growth outlook for PEPGEN INC?

The Earnings per Share (EPS) of PEPGEN INC (PEPG) is expected to grow by 43.77% in the next year.